Key details Disabling condition: Duchenne muscular dystrophy (DMD) is a severe, genetic condition that causes progressive muscle weakness due to the absence of dystrophin, a protein essential for maintaining muscle integrity. Increasing scientific interest in whether...
Key details Current treatment limitations: While ischaemic strokes – which account for nearly 90% of all strokes – are currently treated with clot removal and supportive rehabilitation, there remains a significant unmet need for therapies that directly address...
Key details New trial approval: The South Korean Ministry of Food and Drug Safety has approved a Phase 2a trial for a new umbilical cord stem cell therapy to treat Charcot-Marie-Tooth disease (CMT), one of the most commonly inherited nerve diseases.[1] Early clinical...
Chronic complete spinal cord injury (SCI) is a life-altering diagnosis that severs communication between the brain and body, leading to a permanent loss of movement and sensation for which no restorative treatments currently exist.[1] However, a groundbreaking...
A recent phase 1 trial has found that umbilical cord stem cell eye drops could help relieve the symptoms of dry eye for patients with a severe, treatment-resistant form of the condition. What is dry eye? Dry eye is a chronic condition where either the eyes do not...
Positive early results have emerged from a clinical trial testing an umbilical cord tissue stem cell therapy for epidermolysis bullosa (EB), a currently incurable group of disorders which causes extremely fragile skin. The therapy has shown promise in relieving...
Stem Cell Therapy Potential for Duchenne Muscular Dystrophy
Stem Cell Therapy Shows Promise for Ageing Frailty
Clinical Trial Explores Placental Stem Cell Gel for Radiotherapy Skin Damage
